PTIX Protagenic Therapeutics, Inc.

NASDAQ
$0.80

Protagenic Therapeutics, Inc. (PTIX) Institutional Ownership

What the institutions did with PTIX last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
4
filed a 13F this quarter
Managers holding
2
-2 on the quarter
Buyers
0
0 opened new
Sellers
2
2 sold out entirely
Buyer share
0.0%
of managers who traded it
Breadth
-100.0
net buyers, as a share of those trading

Only 4 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
DRW Securities, LLC 41.8K 62.6%
FNY Investment Advisers, LLC 25.0K 37.4%

Largest changes

Manager Action Previous Current Change
CoreCap Advisors, LLC Sold Out 100 0 -100
United Financial Planning Group LLC Sold Out 17 0 -17

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.